Marker for detecting pancreatic cancer
A pancreatic cancer and marker technology, applied in the field of pancreatic cancer detection, can solve the problems of sufficient sensitivity or specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0031] Next, the present invention will be described in detail.
[0032] It is known from the present invention that for the serum test samples collected from healthy persons, chronic pancreatitis patients and pancreatic cancer patients (before and after surgery), the specificity in the serum of pancreatic cancer is carried out by using glycoprotein extraction and TMT reagent quantification. As a result of the identification of the sex glycoprotein, compared with the sera from healthy persons, patients with chronic pancreatitis, and pancreatic cancer patients (after surgery), there is a high level of C4BPA as a glycoprotein in the serum from pancreatic cancer patients (before surgery) or PIGR, thus finding that C4BPA and PIGR can be markers of pancreatic cancer.
[0033] The markers for detecting pancreatic cancer of the present invention include C4BPA or PIGR. C4BPA, the C4b-binding protein alpha chain, is a glycoprotein represented by the UniProt accession number P04003 (ht...
Embodiment 1
[0060] 【Identification of pancreatic cancer markers】
[0061] The serum test samples collected from 45 healthy persons, 25 patients with chronic pancreatitis, and 57 patients with pancreatic cancer were used to explore and identify pancreatic cancer markers.
[0062] 【A. Method】
[0063] [1. Subject's serum]
[0064] Serum test samples collected from 45 healthy subjects, 25 patients with chronic pancreatitis, and 57 patients with pancreatic cancer were used as serum for the exploration and identification of pancreatic cancer markers.
[0065] [2. Extraction of glycoproteins from each pooled serum]
[0066] The sera of 5 healthy persons, patients with chronic pancreatitis, and patients with pancreatic cancer (before operation-after operation) were randomly extracted and combined to obtain 3 types of combined sera.
[0067] Using a fucose-specific lectin, VECTREX AAL binding and elution kit, which is a retrieval kit for glycoproteins utilizing A. aurantia aurantia lectin (AAL...
Embodiment 3
[0089] [Usefulness of C4BPA and PIGR as pancreatic cancer markers]
[0090] The usefulness of C4BPA and PIGR as pancreatic cancer markers was verified by measuring C4BPA or PIGR in the test sample by ELISA using anti-C4BPA antibody or anti-PIGR antibody. In addition, the usefulness of C4BPA and PIGR as pancreatic cancer markers was also verified by evaluation using ROC curves, which are generally performed, for diagnostic tests or screening tests and comparisons with precision evaluation or conventional methods.
[0091] [1. Measurement of C4BPA or PIGR by ELISA]
[0092] 【(1) Method】
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com